<?xml version="1.0" encoding="UTF-8"?>
<p id="par0070">Finally, rates of morbidity and mortality due to stroke may present a discreet increase as a result of such indirect mechanisms as patientsâ€™ fear of attending hospital or the fact that nearly all hospital resources are occupied in caring for patients with COVID-19. This has resulted in longer cardiac and cerebrovascular reperfusion times,
 <xref rid="bib0210" ref-type="bibr">42</xref>, 
 <xref rid="bib0215" ref-type="bibr">43</xref> which has led professional organisations to issue recommendations on adapting the treatment of stroke
 <xref rid="bib0220" ref-type="bibr">44</xref>, 
 <xref rid="bib0225" ref-type="bibr">45</xref> and myocardial infarction
 <xref rid="bib0230" ref-type="bibr">
  <sup>46</sup>
 </xref> during the pandemic. Stroke incidence may also increase because of decreased monitoring of cardiovascular risk factors as a result of reduced healthcare provision
 <xref rid="bib0235" ref-type="bibr">
  <sup>47</sup>
 </xref> and lockdown measures.
 <xref rid="bib0240" ref-type="bibr">
  <sup>48</sup>
 </xref>
</p>
